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Antibiotic Prescribing for Acute Respiratory Tract 
Infections 12 Months After Communication 
and CRP Training: A Randomized Trial
ABSTRACT
PURPOSE C-reactive-protein (CRP) is useful for diagnosis of lower respiratory 
tract infections (RTIs). A large international trial documented that Internet-based 
training in CRP point-of-care testing, in enhanced communication skills, or both 
reduced antibiotic prescribing at 3 months, with risk ratios (RRs) of 0.68, 0.53, 
0.38, respectively. We report the longer-term impact in this trial.
METHODS A total of 246 general practices in 6 countries were cluster-random-
ized to usual care, Internet-based training on CRP point-of-care testing, Internet-
based training on enhanced communication skills and interactive booklet, or 
both interventions combined. The main outcome was antibiotic prescribing for 
RTIs after 12 months.
RESULTS Of 228 practices providing 3-month data, 74% provided 12-month data, 
with no demonstrable attrition bias. Between 3 months and 12 months, prescrib-
ing for RTIs decreased with usual care (from 58% to 51%), but increased with CRP 
training (from 35% to 43%) and with both interventions combined (from 32% to 
45%); at 12 months, the adjusted RRs compared with usual care were 0.75 (95% 
CI, 0.51-1.00) and 0.70 (95% CI, 0.49-0.93), respectively. Between 3 months and 
12 months, the reduction in prescribing with communication training was main-
tained (41% and 40%, with an RR at 12 months of 0.70 [95% CI, 0.49-0.94]). 
Although materials were provided for free, clinicians seldom used booklets and 
rarely used CRP point-of-care testing. Communication training, but not CRP train-
ing, remained efficacious for reducing prescribing for lower RTIs (RR = 0.7195% 
CI, 0.45-0.99, and RR = 0.76; 95% CI, 0.47-1.06, respectively), whereas both 
remained efficacious for reducing prescribing for upper RTIs (RR = 0.60; 95% CI, 
0.37-0.94, and RR = 0.58; 95% CI, 0.36-0.92, respectively).
CONCLUSIONS Internet-based training in enhanced communication skills remains 
effective in the longer term for reducing antibiotic prescribing. The early 
improvement seen with CRP training wanes, and this training becomes ineffective 
for lower RTIs, the only current indication for using CRP testing.
Ann Fam Med 2019;17:125-132. https://doi.org/10.1370/afm.2356.
INTRODUCTION
Acute uncomplicated lower respiratory tract infections (LRTIs) and upper respiratory tract infections (URTIs) are the leading acute presentations in primary care, and most patients still receive anti-
biotics1-4 despite evidence of limited benefit.4-6 Antibiotic resistance is a 
major public health threat, and primary care prescribing has a key role.7
Educational outreach and training in enhanced communication skills 
for clinicians to explore patients’ concerns can reduce antibiotic prescrib-
ing.8-13 Particular concerns for clinicians and patients are complications 
such as pneumonia14,15; here, C-reactive protein (CRP) point-of-care tests 
have utility for diagnosing LRTI.16 Physician training on use of these tests 
reduces antibiotic prescribing by approximately 20% in the short term,8,9 
so several guidelines now advocate use of CRP in this context.17-19
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Evidence for education outreach mostly documents 
highly expert teams helping a small number of prac-
tices, limiting generalizability of these interventions. 
A large pan-European trial, however, documented the 
impact of brief Internet-based physician training on 
use of a CRP point-of-care test and on enhanced com-
munication skills using an interactive patient booklet. 
In the communication group, there was a clinically 
unimportant increase in symptom duration (a second-
ary outcome) of 1 day, but both interventions reduced 
antibiotic prescribing (the primary outcome) by 3 
months, with risk ratios (RRs) of 0.53 and 0.68, respec-
tively, and even greater benefit seen with their combi-
nation, with an RR of 0.38.20 Communication training 
was the most cost-effective intervention.21 It is unclear 
whether either of these brief interventions has longer-
lasting effects on antibiotic use, which is vital to curb 
the emergence of antibiotic resistance. We report the 
impact of the interventions after 12 months.
METHODS
The methods of this trial are given in greater 
detail elsewhere20; a summary is given below. Ethi-
cal approval in the United Kingdom was granted 
by Southampton and South West Hampshire Local 
Research Ethics Committee for Genomics to combat 
Resistance against Antibiotics for Community-acquired 
LRTI in Europe: INternet Training for Reducing antibi-
Otic use trial (short title: GRACE INTRO Trial, REC 
Ref 10/H0502/29). The research sites outside of the 
United Kingdom also obtained ethical approval from 
their local organizations. 
Patients who met the trial’s inclusion criteria 
were given written and verbal information about the 
study and asked for informed consent. There was no 
individual-level consent for data collection at 12 months.
Trial Design and Audits
We chose a cluster design to minimize contamina-
tion within practices. The 4 randomization groups 
facilitated both 2 × 2 factorial analysis and individual 
group analysis.
The second audit to assess antibiotic prescribing 
was added after the trial began. As funding for the 
trial was uncertain, we asked participating clinicians 
for the 12-month audit only after they had completed 
the 3-month audit. Clinical outcomes other than pre-
scribing were not assessed at 12 months because of 
resource limitations as well as the finding of minimal 
impact of the interventions on these outcomes at 3 
months.16 For example, at 3 months, there were no sig-
nificant differences between groups (described below) 
in hospital admissions, with 2 to 12 admissions per 
group, and most due to cardiorespiratory or systemic 
causes (eg, high fever).
Participants and Timeline
Eight primary care research networks invited local 
general practices to participate in the trial. The net-
works covered a range of countries, and their diverse 
health systems, languages, and cultures: England 
(Southampton), Wales (Cardiff), the Netherlands 
(Utrecht), Belgium (Antwerp), Poland (Łódz´ ; Szczecin), 
and Spain (Barcelona; semFYC). Within each practice, 
all clinicians who prescribed antibiotics for RTI could 
participate (including some UK nurse prescribers).
The trial timeline began at baseline with an audit of 
consecutive participants to document usual prescribing 
practices, conducted between October and December 
2010. At the 3-month audit (February-May 2011),20 clini-
cians were asked to recruit 30 consecutive patients with 
LRTI (the main intervention target population) and 5 
with URTI. At the 12-month audit (October 2011-May 
2012), because the interventions had been found effica-
cious for both LRTI and URTI at 3 months,20 both con-
ditions were assessed with no instructions to clinicians 
to preferentially recruit patients with LRTI.
Inclusion Criteria
Included practices were required to have had no prior 
participation in antibiotic stewardship interventions and 
to be able to recruit more than 10 patients at baseline.
Included patients were adults (aged 18 years or 
older) with LRTI or URTI. We defined LRTI as up to 
28 days of cough as the most prominent symptom, or 
if not (eg, chills most prominent), the clinician judged 
the condition to be LRTI. Patients with pneumonia 
and chronic airway disease were included because 
their management could have been modified by the 
interventions. URTI was defined as clinician-judged 
other RTI (sore throat, otitis media, sinusitis, influenza, 
coryzal illness, or some combination thereof). Patients 
were excluded if they had a noninfective diagnosis (eg, 
pulmonary embolus), had recently received antibiotics 
(within the previous 28 days), were unable to provide 
informed consent (eg, because of dementia), were preg-
nant, or had immune deficiencies.
Randomization, Arms, and Interventions
Practices were remotely randomized using the mini-
mization approach, based on practice characteristics 
(baseline prescribing, number of clinicians, number of 
patients at baseline) and with stratification by network. 
The 2 interventions, communication training and CRP 
training, were developed to be sensitive to cultural dif-
ferences22 while retaining core features. Practices were 
randomized into 4 trial arms, as follows. 
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In the usual care arm, no intervention was provided. 
In the CRP arm, practices were given Internet-based 
training on use of a CRP point-of-care test. The test 
device was demonstrated by company representatives; 
the Internet training provided guidance on CRP use 
(Supplemental Appendix 1, available at http://www.
AnnFamMed.org/content/17/2/125/suppl/DC1/). The 
device and testing materials were provided free. In the 
communication arm, practices were given Internet-based 
training on enhanced communication skills and use of an 
interactive patient booklet (Supplemental Appendix 1). 
The training focused on interactive use of the booklet 
in consultations and enhanced patient-centered commu-
nication—eliciting concerns/expectations, exchanging 
information, agreeing on management, summing up, and 
applying safety-net methods—supported by short dem-
onstration video clips. The booklet included information 
about causes of symptoms, natural history, antibiotics, 
self-help, and when to consult the practice again. Group 
practices appointed a lead physician to organize a struc-
tured meeting on prescribing. In the combined interven-
tion arm, practices received both the CRP intervention 
and the communication intervention.
Outcomes
Clinicians used case report forms to document symp-
toms and signs, and illness duration; use of CRP and 
booklets; and antibiotic prescribing. The trial’s primary 
outcome was antibiotic prescribing documented in the 
case report form by the recruiting clinician. Limited 
availability of prescription monitoring precluded use of 
pharmacy dispensing data.
Sample Size and Analysis 
The sample size was calculated for an α of .025 and 
a β of .2. We assumed that 30 patients per practice 
would be recruited; that a 50% to 40% reduction in 
antibiotic prescribing would be achieved for at least 1 
of the interventions8,23; and that the intracluster corre-
lation coefficient would range from 0.168,24,25 to 0.06.26 
We therefore required 2,600 patients (intracluster cor-
relation coefficient = 0.06) to 5,400 patients (intraclus-
ter correlation coefficient = 0.16).
We used multilevel logistic regression modeling 
for a factorial study, controlling for baseline antibiotic 
prescribing rate, clustering by physician and practice, 
whether the patient had a URTI or LRTI, and a range of 
potential confounders. There was no additional effect 
of international network; hence, it was not included 
in models. We undertook a secondary analysis for the 
individual randomization groups because the study was 
not powered for interactions. The odds ratios were con-
verted to RRs.27 Analysis was conducted on an intention-
to-treat basis. To assess attrition bias (1) we used data 
aggregated at the practice level, and multiple imputation 
to impute data from practices that had not agreed to be 
followed up, and (2) we compared estimates at 3 months 
just for those practices followed up at 12 months.
RESULTS
Participants and Follow-up
At the baseline audit, 5,355 patients (79.1%) had LRTI 
and 1,416 (20.9%) had URTI. Overall, 3,742 (55%) 
were prescribed antibiotics. 
A total of 372 participating clinicians in 228 of 
246 practices contributed data for 4,264 patients at 
the 3-month follow-up (Figure 1), of whom 20% had 
URTI. Of the 228 practices providing 3-month data, 
168 (74%) provided 12-month data. A total of 247 clini-
cians in these 168 practices contributed data for 4,830 
patients at the 12-month follow-up, of whom 41% had 
URTI; hence, we controlled for URTI in the estimates. 
The groups were well balanced at 3 months and 
remained so at 12 months (Table 1). Initial compliance 
with training was good, with most clinicians complet-
ing all modules: CRP, 99 of 113 (88%); communication, 
94 of 108 (87%); and combination, 116 of 127 (91%).
Use of Study Materials
By 12 months, clinicians in all groups had seldom used 
CRP testing in patient care, even though they were 
given free access to CRP diagnostic kits: usual care, 16 
of 1,195 (1.34%); CRP, 62 of 1,075 (5.77%); commu-
nication, 56 of 1,168 (4.79%); and combination, 85 of 
1,419 (5.99%). Booklets were used fairly sparingly too: 
communication, 189 of 1,186 (16%) and combination, 
340 of 1,428 (24%). 
Efficacy of the Interventions
Factorial Analysis
Results of factorial analysis showed that at 3 months, 
48% (984 of 2,040) of the patients consulting clini-
cians who were not trained in using CRP were pre-
scribed antibiotics, and by 12 months, the value was 
little changed, at 46% (1,078 of 2,360) (Table 2). The 
antibiotic prescribing rate in the CRP groups was 33% 
(734 of 2,224) at 3 months but 45% (1,097 of 2,462) at 
12 months; however, the adjusted RR was a nonsignifi-
cant 0.87 compared with the no-training control at 12 
months (95% CI, 0.68-1.06; P = .18). 
At 3 months, 45% (876 of 1,932) of the patients 
consulting clinicians who were not trained in enhanced 
communication were prescribed antibiotics, and simi-
larly, at 12 months, 48% (1,069 of 2,246) were. The 
antibiotic prescribing rate in the communications 
groups was 36% (842 of 2,332) at 3 months but 43% 
(1,106 of 2,576) at 12 months; the adjusted RR com-
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pared with no training at 12 months was a significant 
0.81 (95% CI, 0.64-1.00; P = .049).
Analysis of Individual Groups
The factorial analysis probably masks effectiveness 
of individual interventions 
because there was a sizable 
interaction term between 
the CRP and communication 
interventions (1.67; P = .16). 
The individual group analysis 
yielded somewhat different 
results (Table 3). 
Among patients receiving 
usual care, whose clinicians 
received no training, 58% (508 
of 870) were prescribed antibi-
otics at 3 months, and the value 
had decreased by an absolute 
7%, to 51% (613 of 1,194), at 
12 months in part due to more 
cases of URTI. Prescribing in 
the CRP group, however, rose 
by almost 9% from 35% (368 
of 1,062) at 3 months to 43% 
(456 of 1,052) at 12 months 
(adjusted RR compared with 
usual care at 12 months = 0.75; 
95% CI, 0.51-1.00; P = .052). 
Similarly, among patients in 
the combined intervention 
group, 32% (476 of 1,170) 
were prescribed antibiotics 
at 3 months, with an absolute 
13% increase to 45% (641 of 
1,410) at 12 months (adjusted 
RR compared with usual care 
at 12 months = 0.70; 95% CI, 
0.49-0.93; P = .01). Among those in the communication 
group, 41% (476 of 1,170) were prescribed antibiotics at 
3 months, with virtually no change by 12 months, 40% 
(465 of 1,166) (adjusted RR compared with usual care at 
12 months = 0.70; 95% CI, 0.49-0.94; P = .02). 
Figure 1. CONSORT flow diagram.
246 Practices randomized
Baseline data audit 
6,671 Patients in 259 practices
13 Practices not randomized 
(did not recruit 10 patients 
during baseline audit)
259 Practices eligible
259 Practices agreed
446 Practices invited
Internet CRP 
training
62 Practices
3 Months
58 Practices
1,062 Patients
12 Months
39 Practices
1,060 Patients
Internet commu-
nication training
61 Practices
3 Months
55 Practices
1,170 Patients
12 Months
41 Practices
1,165 Patients
Usual care 
61 Practices 
3 Months
53 Practices
870 Patients
12 Months
40 Practices
1,194 Patients
Internet CRP/
Communication 
training
62 Practices
3 Months
62 Practices
1,162 Patients
12 Months
58 Practices
1,411 Patients 
CONSORT =Consolidated Standards of Reporting Trials; CRP = C-reactive protein.
Table 1. Patient Characteristics
Characteristic
Baseline 
(n = 6,771)
3 Months of Follow-up  12 Months of Follow-up
CRP Training Communication Training  CRP Training Communication Training
Control 
(n = 2,040)
Intervention 
(n = 2,224)
Control 
(n = 1,932)
Intervention 
(n = 2,332)  
Control 
(n = 2,463)
Intervention 
(n = 2,699)
Control 
(n = 2,464)
Intervention 
(n = 2,698)
Sex, female, No. (%) 4,218 (62) 1,311 (64) 1,423 (64) 1,223 (63) 1,511 (65) 1,470 (60) 1,620 (60) 1,466 (60) 1,624 (60)
Age, mean (SD), y 49.6 (18.6) 50.9 (17.3) 51.0 (17.5) 50.8 (17.6) 51.1 (17.2) 51.7 (18.8) 51.2 (18.7) 51.1 (18.6) 51.7 (18.8)
Never-smoker, No. (%) N/A 1,067 (52) 1,147 (52) 1,041 (54) 1,173 (50) N/A N/A N/A N/A
Illness duration before index consultation ≥5 days, No. (%) 3,542 (53)a 1,038 (51)a 1,128 (51)a 994 (52)a 1,172 (51)a 1,026 (42) 1,198 (44) 1,032 (42) 1,192 (44)
Respiratory rate ≥25 breaths/minute, No. (%) N/A 101 (5)a 123 (6)a 145 (8)a 79 (3)a 65 (3)a 133 (5) 96 (4) 102 (4)
Temperature ≥38°C, No. (%) N/A 228 (11)a 280 (13)a 202 (11)a 306 (13)a 291 (12) 380 (14) 285 (12) 386 (14)
CRP = C-reactive protein; N/A = not available.
a Data missing for some patients.
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Results differed somewhat by type of RTI. For 
patients with LRTI, communication was still effec-
tive compared with usual care at 12 months (adjusted 
RR = 0.71; 95% CI, 0.45-0.99), but CRP was not 
(adjusted RR = 0.76; 95% CI, 0.47-1.06). For patients 
with URTI, benefit of both interventions relative to 
usual care was maintained at 12 months: communica-
tions (adjusted RR = 0.60; 95% CI, 0.37-0.94; P = .02) 
and CRP (adjusted RR = 0.58; 95% CI, 0.36-0.92; 
P = .02).
Assessment of Attrition Bias
Data from practices where follow-up was possible 
were comparable to those for the entire trial popula-
tion (Supplemental Appendix 2, Supplemental Table 5, 
and Supplemental Table 6, available at http://www.
AnnFamMed.org/content/17/2/125/suppl/DC1/). In 
our practice-level analysis, we compared results for 
the practices completing follow-up at 12 months with 
estimates for all practices that were derived with impu-
tation for missing data (Table 4). Although the absolute 
estimates of efficacy differed slightly, with lower power 
and less robustness (because of inability to control for 
individual patient characteristics), there was no mean-
ingful change in the practice-based estimates. This 
finding suggests that there was minimal attrition bias 
related to practices not completing the study. 
As a further check, we determined that estimates 
at 3 months from completers were also very similar to 
results for the whole trial cohort. The RRs were 0.54 
for CRP and 0.68 for communication among com-
pleters, and 0.54 and 0.69, respectively, among the 
whole trial cohort. 
DISCUSSION
As far as we are aware, this is the first major multi-
center international trial to assess longer-term effec-
tiveness of Internet-based training to modify antibiotic 
prescribing for RTIs. Although antibiotic prescribing 
decreased with usual care during follow-up out to 12 
months, communication training remained more effica-
cious at that time, whereas CRP training did not.
Potential Limitations
Our trial had a number of potential limitations. Prac-
tices were approached only after 3 months to request 
further follow-up, and 26% of those providing 3-month 
data declined to continue. Baseline characteristics, 
however, were similar for practices that were not fol-
lowed up, and the practice-level analysis using multiple 
imputation demonstrated no attrition bias. The major-
ity of practices approached agreed, and many of them 
had not previously taken part in research. 
As expected, clinicians reported struggling to docu-
ment consecutive patients at busy times of year. But 
previous research has shown this challenge results in 
little selection bias,28,29 and there were minimal bar-
riers to participation for the 12-month audit (the trial 
used quick audit proformas, and there was no delay 
for patient consent). Antibiotic prescribing was similar 
to that seen in previous studies,2,4 and at baseline, the 
majority of patients in usual care received antibiotics, 
which suggests the trial’s results are generalizable. 
There was no evidence of differential selection 
bias comparing groups, and analysis controlled for 
differences in case mix. At 12 months, usual care pre-
scribing had fallen slightly, by 7%, perhaps because 
of pressure on clinicians (eg, the European Antibiotic 
Awareness Day), but also, there were more patients 
with URTI at that time point, which explained one-
half the reduction. The findings cannot be explained 
by case mix, however, because we controlled for a 
range of variables in the analysis. We checked fidelity 
with initial training but did not observe actual con-
sultations (to avoid influencing behavior). We did not 
record other clinical outcomes at 12 months given the 
modest impact seen at 3 months.20
Comparison With Other Studies
In this trial, the benefit of communication training 
was durable, supporting prior evidence for interactive 
methods.10,11 Our process evaluation also indicated 
that communication training promoted changes in 
physician attitudes that should be helpful in the lon-
ger term.22,30,31 The Stemming the Tide of Antibiotic 
Resistance (STAR) trial achieved a 4% reduction in 
overall antibiotic prescribing but was more intensive 
(5 online phases vs 1 in this study, plus expert-led out-
reach seminars).13 Our intervention yielded less initial 
reduction than the Dutch IMPAC3T trial,8 but that 
trial was also more intensive, with face-to-face com-
Table 1. Patient Characteristics
Characteristic
Baseline 
(n = 6,771)
3 Months of Follow-up  12 Months of Follow-up
CRP Training Communication Training  CRP Training Communication Training
Control 
(n = 2,040)
Intervention 
(n = 2,224)
Control 
(n = 1,932)
Intervention 
(n = 2,332)  
Control 
(n = 2,463)
Intervention 
(n = 2,699)
Control 
(n = 2,464)
Intervention 
(n = 2,698)
Sex, female, No. (%) 4,218 (62) 1,311 (64) 1,423 (64) 1,223 (63) 1,511 (65) 1,470 (60) 1,620 (60) 1,466 (60) 1,624 (60)
Age, mean (SD), y 49.6 (18.6) 50.9 (17.3) 51.0 (17.5) 50.8 (17.6) 51.1 (17.2) 51.7 (18.8) 51.2 (18.7) 51.1 (18.6) 51.7 (18.8)
Never-smoker, No. (%) N/A 1,067 (52) 1,147 (52) 1,041 (54) 1,173 (50) N/A N/A N/A N/A
Illness duration before index consultation ≥5 days, No. (%) 3,542 (53)a 1,038 (51)a 1,128 (51)a 994 (52)a 1,172 (51)a 1,026 (42) 1,198 (44) 1,032 (42) 1,192 (44)
Respiratory rate ≥25 breaths/minute, No. (%) N/A 101 (5)a 123 (6)a 145 (8)a 79 (3)a 65 (3)a 133 (5) 96 (4) 102 (4)
Temperature ≥38°C, No. (%) N/A 228 (11)a 280 (13)a 202 (11)a 306 (13)a 291 (12) 380 (14) 285 (12) 386 (14)
CRP = C-reactive protein; N/A = not available.
a Data missing for some patients.
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munication training. The long-term effect on behavior 
in our study was similar to that seen with other, more 
intensive interventions.8,13,32 Booklets were initially 
important, but their limited use in follow-up—despite 
the intervention’s persistent efficacy—suggests that 
clinicians had consolidated skills and were being more 
selective in using this resource.
Communication was slightly less effective than 
CRP training or the combined intervention at 3 
months (RRs = 0.68 vs 0.53 and 0.38, respectively), 
a finding comparable to the trend seen in the Dutch 
trials.8,9 Even though all materials were provided for 
free, CRP tests were little used by 12 months, and 
the effectiveness of CRP training had waned substan-
tially (RRs = 0.70, 0.75, and 0.70, respectively)—but 
the diminished impact was particularly pronounced 
among patients with LRTI, where use of CRP to guide 
prescribing is supported.17-19 Our findings support 
long-term findings for LRTI from the smaller, intensive 
IMPAC3T trial, where there was no longer a significant 
effect of CRP training at follow-up, but the effect of 
communication training persisted.32 The waning in effi-
cacy of CRP training may reflect the general waning of 
quality improvement interventions over time, although 
no similar effect occurred with communication train-
ing. It is unclear whether further reduction in the effi-
Table 3. Individual Group Analysis: Efficacy of Interventions in Reducing Antibiotic Prescribing 
at 12 Months
Measure
Usual Care 
(n = 1,194)
CRP Training 
(n = 1,052)
Communication 
Training (n = 1,166)
Combination 
(n = 1,410)
Patients prescribed antibiotics, No. (%) 613 (51.3) 456 (43.4) 465 (39.9) 641 (45.5)
Basic risk ratio (95% CI) [P value]a ref 0.83 (0.66-1.02) [.08] 0.83 (0.66-1.01) [.07] 0.83 (0.66-1.00) [.053]
Fully adjusted risk ratio (95% CI) [P value]b ref 0.75 (0.51-1.00) [.052] 0.70 (0.49-0.94) [.02] 0.70 (0.49-0.93) [.01]
CRP = C-reactive protein; ref = reference group.
a The basic model adjusted for baseline prescribing and clustering by physician and practice. 
b The fully adjusted model controlled for the variables listed under Table 1.
Table 2. Factorial Analysis: Efficacy of Interventions in Reducing Antibiotic Prescribing at 12 Months
Measure
No CRP Training 
(n = 2,360)
CRP Training 
(n = 2,462)
No Communication 
Training (n = 2,246)
Communication 
Training (n = 2,576)
Patients prescribed antibiotics, No. (%) 1,078 (45.7) 1,097 (44.6) 1,069 (47.6) 1,106 (42.9)
Basic risk ratio (95% CI) [P value]a ref 0.91 (0.77-1.05) [.22] ref 0.90 (0.77-1.04) [.17]
Fully adjusted risk ratio (95% CI) [P value]b ref 0.87 (0.68-1.06) [.18] ref 0.81 (0.64-1.00) [.049]
CRP = C-reactive protein; ref = reference group.
a The basic model adjusted for baseline prescribing and clustering by physician and practice. 
b The fully adjusted model controlled for diagnosis (lower respiratory tract infection, upper respiratory tract infection, pneumonia), sex, age, presence of cough, 
phlegm, shortness of breath, blocked/runny nose, chest pain, fever, muscle ache, headache, disturbed sleep, feeling generally unwell, interference with social activities, 
earache, sore throat, facial/sinus pain, crackles, wheeze, pulse >100 beats per minute, temperature >37.8°C, respiratory rate, physician’s rating of severity, low blood 
pressure, duration of cough, and duration of illness before consultation.
Table 4. Assessment of Attrition Bias: Completing Practices and All Practices With Imputation
Measure Usual Care CRP Training Communication Training Combination
Practices completing 12 months of follow-up     
Patients prescribed antibiotics, % 51.0 42.9 39.8 47.1
Difference, % (95% CI) [P value]a ref –7 (–15 to 2) [.11] –7 (–15 to 1) [.09] –4 (–12 to 4) [.30]
All practices, with imputation for missing data     
Patients prescribed antibiotics, % 49.7 42.9 41.9 47.0
Difference, % (95% CI) [P value]a ref –6 (–14 to 3) [.22] –7 (–15 to 1) [.10] –4 (–12 to 4) [.34]
CRP = C–reactive protein; ref = reference group.
Note: A practice-level analysis.
a Reduction in proportion compared with usual care controlling for baseline prescribing and practice-level averages of patient characteristics: age, type of infection 
(lower respiratory tract infection vs upper respiratory tract infection), presence of symptoms (crackles, wheeze, pulse higher than 100 beats per minute, temperature 
higher than 37.8°C), respiratory rate, physician’s rating of severity, and duration of cough.
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cacy of CRP training would occur beyond 12 months. 
The logistics of providing this training and the time 
required to do the test at the busiest times of year may 
also be key disincentives to longer-term engagement. 
The persistent benefit of CRP training in reduc-
ing antibiotic prescribing for URTI despite low use 
of CRP may be due to clinicians having learned to 
prescribe fewer antibiotics when using CRP, or to the 
training content for both CRP and communication, 
which shared introductory modules about the limited 
benefit of antibiotics, that is, that they have a non-
specific effect that is possibly unrelated to CRP per 
se. Ongoing incentives would probably be needed for 
clinicians to continue using CRP testing, but evidence 
of cost-effectiveness of this approach would be needed. 
As communication training was the most cost-effective 
option at 3 months when allowing for the costs of anti-
biotic resistance,21 its lasting impact makes it likely to 
be even more cost-effective.
Conclusion
Internet-based training in enhanced communication 
skills to reduce antibiotic prescribing for RTI remains 
efficacious in the longer term. In contrast, an early 
improvement with CRP training wanes over time, 
and this strategy becomes ineffective long term both 
overall and for LRTI, the only current indication for 
using CRP to guide decisions about antibiotic therapy. 
Our trial’s findings suggest there is probably only 
short-term benefit from training clinicians in routine 
primary care to use CRP. Instead, the most useful 
training for long-lasting effects is likely in enhanced 
communication skills.
To read or post commentaries in response to this article, see it 
online at http://www.AnnFamMed.org/content/17/2/125.
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